Inventor · disambiguated record
Takahiko Hashizuka
Also filed as: HASHIZUKA TAKAHIKO
4 granted patents·3 pending applications·13 citations·filing 2019–2024
71Inventor score
Files withSUMITOMO PHARMA ONCOLOGY INC3SUNOVION PHARMACEUTICALS INC2SUMITOMO DAINIPPON PHARMA ONCOLOGY INC1SUMITOMO PHARMA AMERICA INC1
Top patents by PatentIndex Score
7 records- 0195US11530231B2CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancerSUMITOMO PHARMA ONCOLOGY INC·Filed 2021·Granted Dec 20, 2022·5 cites·21 claims
- 0293US11034710B2CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancerSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2019·Granted Jun 15, 2021·7 cites·28 claims
- 0381US11136304B2Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Oct 5, 2021·1 cites·22 claims
- 0479US2025197432A1CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of CancerSUMITOMO PHARMA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0576US12077554B2CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancerSUMITOMO PHARMA ONCOLOGY INC·Filed 2022·Granted Sep 3, 2024·0 cites·20 claims
- 0669US2024417382A1Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereofSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
- 0763US2022098163A1Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereofSUNOVION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takahiko Hashizuka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →